# US 2016/0237225 A1 · Bioadhesive and injectable hydrogel

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0237225 A1
- Document ID: US20160237225A1
- Status: Published application
- Kind: A1
- Application number: 15/013,657
- Filed: 2016-02-02
- Published: 2016-08-18
- Earliest claimed: 2015-02-12
- Assignees: The Chinese University of Hong Kong
- Applicants: The Chinese University of Hong Kong
- Inventors: Liming BIAN; Qian FENG; Kongchang WEI; Gang LI; Sien LIN
- Web page: https://patentgrep.com/patent/US20160237225A1

## CPC

- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 47/32: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone}
- A61K 47/40: Cyclodextrins; Derivatives thereof
- A61K 47/42: Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34)
- A61L 26/0038: {Gelatin}
- A61L 26/0066: {Medicaments; Biocides}
- A61L 26/008: {Hydrogels or hydrocolloids}
- A61L 27/222: {Gelatin}
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- C08F 289/00: Macromolecular compounds obtained by polymerising monomers on to macromolecular compounds not provided for in groups C08F251/00 - C08F287/00
- A61L 2300/64: Animal cells
- A61L 2400/06: Flowable or injectable implant compositions
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS

## Abstract

The present invention provides a novel hydrogel, methods of its use, and methods for producing the hydrogel.

## Claims

### Claim 1

A method of producing a hydrogel, comprising the steps of:
(1) complexing a host molecule and a guest molecule, wherein the host molecule presents a hydrophobic pocket and comprises a monomer component, and wherein the host molecule and guest molecule form a physical interaction between the hydrophobic pocket and a benzene ring of the guest molecule; and
(2) polymerizing the monomer compoents to form a cross-linked mesh of the host molecules and guest molecules.

### Claim 2 (depends on 1)

The method of claim 1, wherein the host molecule is an acrylated β-cyclodextrin.

### Claim 3 (depends on 1)

The method of claim 1, wherein the monomer component is an acrylate.

### Claim 4 (depends on 1)

The method of claim 1, wherein the guest molecule is a gelatin.

### Claim 5 (depends on 1)

The method of claim 1, wherein the polymerization is initiated by UV radiation.

### Claim 6 (depends on 1)

The method of claim 1, wherein the host molecule and the guest molecule are placed in an aqueous solution together.

### Claim 7 (depends on 1)

The method of claim 1, wherein at least one additional molecule is present in step (1) when the host molecule and the guest molecule are complexed.

### Claim 8 (depends on 7)

The method of claim 7, wherein the at least one additional molecule is a pharmaceutically active ingredient.

### Claim 9 (depends on 1)

The method of claim 1, wherein the host molecule is a mono-acrylated β-cyclodextrin and the guest molecule is a gelatin.

### Claim 10

A hydrogel comprising a cross-linked mesh of a host molecule and a guest molecule, wherein the host molecule presents a hydrophobic pocket and comprises a monomer component, the host molecule and guest molecule forming a physical interaction between the hydrophobic pocket and a benzene ring of the guest molecule, and wherein the monomer components are polymerized to form the cross-linked mesh.

### Claim 11 (depends on 10)

The hydrogel of claim 10, wherein the host molecule is an acrylated β-cyclodextrin.

### Claim 12 (depends on 10)

The hydrogel of claim 10, wherein the monomer component is an acrylate.

### Claim 13 (depends on 10)

The hydrogel of claim 10, wherein the guest molecule is a gelatin.

### Claim 14 (depends on 10)

The hydrogel of claim 10, wherein the host molecule is a mono-acrylated β-cyclodextrin and the guest molecule is a gelatin.

### Claim 15 (depends on 1, 10)

The hydrogel of claim 10, which is generated by the method of claim 1.

### Claim 16 (depends on 10)

The hydrogel of claim 10, formulated in an injectable form.

### Claim 17 (depends on 10)

The hydrogel of claim 10, further comprising at least one additional molecule.

### Claim 18 (depends on 17)

The hydrogel of claim 17, wherein the at least one additional molecule is a pharmaceutically active ingredient.

### Claim 19 (depends on 10)

The hydrogel of claim 10, further comprising a live cell.

### Claim 20 (depends on 19)

The hydrogel of claim 19, wherein the live cell is a live stem cell.

### Claim 21 (depends on 18)

A method for delivering of a pharmaceutically active ingredient, comprising administrating to a patient the hydrogel of claim 18.

### Claim 22 (depends on 20)

A method for promoting cell proliferation or differentiation, comprising the step of administering to a patient the hydrogel of claim 20.

### Claim 23 (depends on 22)

The method of claim 22, wherein the hydrogel is applied to a wound site in the patient's body.

### Claim 24 (depends on 22)

The method of claim 22, wherein the hydrogel is applied to a surgical wound immediately after a surgical procedure is performed on a patient's body.

### Claim 25

(canceled)
